EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chronic hypoxia impairs skeletal muscle repair via HIF‐2α stabilization

Amelia Yin, Wenyan Fu, Anthony Elengickal, Joonhee Kim, Yang Liu, Anne Bigot, Kamal Mamchaoui, Jarrod A Call, Hang Yin iD

Journal of Cachexia, Sarcopenia and Muscle · 2024-04 · 15 (2) · 631-645

DOI: 10.1002/jcsm.13436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 09.02.2024. Verfasst von Amelia Yin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Medicine, The University of Georgia, Athens, GA, USA. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Indans, Lisinopril, Sulfones. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic hypoxia and skeletal muscle atrophy commonly coexist in patients with COPD and CHF, yet the underlying physio‐pathological mechanisms remain elusive. Muscle regeneration, driven by muscle stem cells (MuSCs), holds therapeutic potential for mitigating muscle atrophy. This study endeavours to investigate the influence of chronic hypoxia on muscle regeneration, unravel key molecular mechanisms, and explore potential therapeutic interventions.

Methods

Experimental mice were exposed to prolonged normobaric hypoxic air (15% p O 2 , 1 atm, 2 weeks) to establish a chronic hypoxia model. The impact of chronic hypoxia on body composition, muscle mass, muscle strength, and the expression levels of hypoxia‐inducible factors HIF‐1α and HIF‐2α in MuSC was examined. The influence of chronic hypoxia on muscle regeneration, MuSC proliferation, and the recovery of muscle mass and strength following cardiotoxin‐induced injury were assessed. The muscle regeneration capacities under chronic hypoxia were compared between wildtype mice, MuSC‐specific HIF‐2α knockout mice, and mice treated with HIF‐2α inhibitor PT2385, and angiotensin converting enzyme (ACE) inhibitor lisinopril. Transcriptomic analysis was performed to identify hypoxia‐ and HIF‐2α‐dependent molecular mechanisms. Statistical significance was determined using analysis of variance (ANOVA) and Mann–Whitney U tests.

Results

Chronic hypoxia led to limb muscle atrophy (EDL: 17.7%, P < 0.001; Soleus: 11.5% reduction in weight, P < 0.001) and weakness (10.0% reduction in peak‐isometric torque, P < 0.001), along with impaired muscle regeneration characterized by diminished myofibre cross‐sectional areas, increased fibrosis ( P < 0.001), and incomplete strength recovery (92.3% of pre‐injury levels, P < 0.05). HIF‐2α stabilization in MuSC under chronic hypoxia hindered MuSC proliferation (26.1% reduction of MuSC at 10 dpi, P < 0.01). HIF‐2α ablation in MuSC mitigated the adverse effects of chronic hypoxia on muscle regeneration and MuSC proliferation (30.9% increase in MuSC numbers at 10 dpi, P < 0.01), while HIF‐1α ablation did not have the same effect. HIF‐2α stabilization under chronic hypoxia led to elevated local ACE, a novel direct target of HIF‐2α. Notably, pharmacological interventions with PT2385 or lisinopril enhanced muscle regeneration under chronic hypoxia (PT2385: 81.3% increase, P < 0.001; lisinopril: 34.6% increase in MuSC numbers at 10 dpi, P < 0.05), suggesting their therapeutic potential for alleviating chronic hypoxia‐associated muscle atrophy.

Conclusions

Chronic hypoxia detrimentally affects skeletal muscle regeneration by stabilizing HIF‐2α in MuSC and thereby diminishing MuSC proliferation. HIF‐2α increases local ACE levels in skeletal muscle, contributing to hypoxia‐induced regenerative deficits. Administration of HIF‐2α or ACE inhibitors may prove beneficial to ameliorate chronic hypoxia‐associated muscle atrophy and weakness by improving muscle regeneration under chronic hypoxia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix ProteinsIndansLisinoprilSulfonesAnimalsMiceHypoxiaMuscle, SkeletalMuscular AtrophyEndothelial PAS Domain-Containing Protein 1

Stichwörter der Autor:innen

Angiotensin converting enzymeHypoxiaHypoxia‐inducible factor 2AMuscle atrophyMuscle regenerationMuscle stem cells

Substanzen

Basic Helix-Loop-Helix ProteinsIndansLisinoprilSulfonesEndothelial PAS Domain-Containing Protein 1PT2385

Autor:innen und Institutionen

  • Center for Molecular Medicine, The University of Georgia, Athens, GA, USA.
  • Department of Biochemistry and Molecular Biology, The University of Georgia, Athens, GA, USA.
  • Sorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, Paris, France.
  • Department of Physiology and Pharmacology, The University of Georgia, Athens, GA, USA.

ORCID-Profile: Hang Yin

Förderung

  • NIAMS NIH HHS
  • NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Small Business Innovation Research

Zitieren

APA

Yin, A., Fu, W., Elengickal, A., Kim, J., Liu, Y., Bigot, A., Mamchaoui, K., Call, J. A., & Yin, H. (2024). Chronic hypoxia impairs skeletal muscle repair via HIF‐2α stabilization. Journal of Cachexia, Sarcopenia and Muscle, 15(2), 631-645. https://doi.org/10.1002/jcsm.13436

Vancouver

Yin A, Fu W, Elengickal A, Kim J, Liu Y, Bigot A, et al. Chronic hypoxia impairs skeletal muscle repair via HIF‐2α stabilization. Journal of Cachexia, Sarcopenia and Muscle. 2024;15(2):631-645. doi:10.1002/jcsm.13436

BibTeX
@article{Yin2024,
  author = {Yin, Amelia and Fu, Wenyan and Elengickal, Anthony and Kim, Joonhee and Liu, Yang and Bigot, Anne and Mamchaoui, Kamal and Call, Jarrod A and Yin, Hang},
  title = {Chronic hypoxia impairs skeletal muscle repair via HIF‐2α stabilization},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2024},
  volume = {15},
  number = {2},
  pages = {631--645},
  doi = {10.1002/jcsm.13436}
}
Kostenlos starten →